Sarepta Therapeutics, Inc. (SRPT): Price and Financial Metrics

SRPT POWR Grades

• SRPT scores best on the Quality dimension, with a Quality rank ahead of 71.46% of US stocks.
• SRPT's strongest trending metric is Quality; it's been moving up over the last 179 days.
• SRPT's current lowest rank is in the Sentiment metric (where it is better than 20.61% of US stocks).

SRPT Stock Summary

• SRPT has a higher market value than 84.21% of US stocks; more precisely, its current market capitalization is $10,970,188,523.
• Of note is the ratio of SAREPTA THERAPEUTICS INC's sales and general administrative expense to its total operating expenses; just 15.29% of US stocks have a lower such ratio.
• SRPT's price/sales ratio is 12.52; that's higher than the P/S ratio of 90.7% of US stocks.
• If you're looking for stocks that are quantitatively similar to SAREPTA THERAPEUTICS INC, a group of peers worth examining would be ONCT, SLDP, UBX, STRO, and EXAI.
• SRPT's SEC filings can be seen here. And to visit SAREPTA THERAPEUTICS INC's official web site, go to www.sarepta.com.

SRPT Valuation Summary

• In comparison to the median Healthcare stock, SRPT's price/sales ratio is 137.25% higher, now standing at 12.1.
• SRPT's price/sales ratio has moved down 105.4 over the prior 243 months.

Below are key valuation metrics over time for SRPT.

SRPT Growth Metrics

Its 2 year net cashflow from operations growth rate is now at -214.62%.
• Its 4 year revenue growth rate is now at 1772.43%.
• Its 4 year price growth rate is now at 266.98%.

Over the past 33 months, SRPT's revenue has gone up $495,214,000.

The table below shows SRPT's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	876.047	-262.28	-716.225
2022-06-30	835.184	-321.645	-506.631
2022-03-31	765.786	-363.976	-356.555
2021-12-31	701.887	-443.172	-418.78
2021-09-30	645.564	-588.381	-486.116
2021-06-30	600.082	-702.238	-634.471

SRPT's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• SRPT has a Quality Grade of C, ranking ahead of 59.75% of graded US stocks.
• SRPT's asset turnover comes in at 0.231 -- ranking 185th of 682 Pharmaceutical Products stocks.
• ORMP, AGIO, and JAZZ are the stocks whose asset turnover ratios are most correlated with SRPT.

The table below shows SRPT's key quality metrics over time.